Molecular characterization of the guinea-pig cytomegalovirus glycoprotein L gene

Archives of Virology

Volumn 144, Issue 3, 1999, Pages 447-462

  Paglino, J C ^a,b   Brady, R C ^a   Schleiss, M R ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAY; BETA HERPESVIRUS; DNA GLYCOSYLTRANSFERASE; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN L; GLYCOPROTEIN; GUINEA PIG CYTOMEGALOVIRUS; HUMAN CYTOMEGALOVIRUS; HYBRID PROTEIN; OPEN READING FRAME; SEQUENCE ANALYSIS; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA GLYCOSYLASES; DNA, VIRAL; GENES, VIRAL; GENOME, VIRAL; GUINEA PIGS; HUMANS; MOLECULAR SEQUENCE DATA; N-GLYCOSYL HYDROLASES; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; URACIL-DNA GLYCOSIDASE; VIRAL PROTEINS;

CAVIA PORCELLUS; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; ESCHERICHIA COLI; GUINEA PIG CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; SUS SCROFA;

EID: 0032938737     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050050517     Document Type: Article

References (46)

1. 1. Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, Manning ML, Best AM (1995) Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 171: 26-32
2. 2. Anderson RA, Liu DX, Gompels UA (1996) Definition of a human herpesvirus-6 betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology 217: 517-526
3. 3. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA (1992) Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11: 93-99
4. 4. Brady RC, Schleiss MR (1996) Identification and characterization of the guinea pig cytomegalovirus glycoprotein H gene. Arch Virol 141: 2 409-2 424
5. 5. Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI (1995) Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis 72: 944-950
6. 6. Britt WJ, Alford CA (1996) Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Strauss SE (eds) Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, pp 2 493-2 523
7. 7. Britt WJ, Vugler L, Butfiloski EJ, Stephens EB (1990) Cell surface expression of human cytomegalovirus (HCMV) gp 55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J Virol 64: 1 079-1 085
8. 8. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerney R, Horsnell T, Hutchinson CA, Kouzarides T, Martignetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG (1990) Analysis of the protein coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154: 125-169
9. 9. Cranage MP, Smith GL, Bell SE, Hart H, Brown C, Bankier AT, Tomlinson P, Barrell BG, Minson TC (1988) Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicellazoster virus gpIII, and herpes simplex virus type I glycoprotein H. J Virol 62: 1 416-1 422
10. 10. Demmler G (1991) Infectious Diseases Society of America and Centers for Disease Control: Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13: 315-329
11. 11. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326: 663-667
12. 12. Gao M, Isom HC (1984) Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J Virol 52: 436-447
13. 13. Geballe AP, Mocarski ES (1988) Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol 62: 3 334-3 340
14. 14. Gompels UA, Minson A (1989) Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. J Virol 63: 4 744-4 755
15. 15. Gompels UA, Carss AL, Saxby C, Hancock DC, Forrester A, Minson A (1991) Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H. J Virol 65: 2 393-2 401
16. 16. Gretch DR, Kari B, Rasmussen L, Gehrz RC, Stinski MF (1988) Identification and characterization of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus. J Virol 62: 875-881
17. 17. Griffith BP, McCormick SR, Fong CKY, Lavallee JT, Lucia HL, Goff E (1985) The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 55: 402-409
18. 18. Griffith BP, Aquino-De Jesus MJC (1991) Guinea pig model of congenital cytomegalovirus infection. Transplant Proc 23: 29-31
19. 19. Huber MT, Compton T (1997) Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J Virol 71: 5 391-5 398
20. 20. Huber MT, Compton T (1998) The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing complex. J Virol 72: 8 191-8 197
21. 21. Kaye JF, Gompels UA, Minson AC (1992) Glycoprotein H of human cytomegalovirus (HCMV) forms a stable complex with the HCMV UL115 gene product. J Gen Virol 73: 2 693-2 698
22. 22. Kozak M (1984) Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res 12: 857-872
23. 23. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
24. 24. Li L, Coelingh KL, Britt WJ (1995) Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J Virol 69: 6 047-6 053
25. 25. Li L, Nelson JA, Britt WJ (1997) Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex. J Virol 71: 3 090-3 097
26. 26. Maniatis T, Fritsch EF, Sambrook J (1992) Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
27. 27. Meyer TE, Habener JF (1993) Cyclic adenosine 3′, 5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocrine Rev 14: 269-290
28. 28. Milne RSB, Paterson DA, Booth JC (1998) Human cytomegalovirus glycoprotein H/glycoprotein L complex mediates fusion-from-without. J Gen Virol 79: 855-865
29. 29. Plotkin SA, Starr SE, Friedman HM, Brayman K, Harris S, Jackson S, Tustin NB, Grossman R, Dafoe D, Barker C (1991) Effect of Towne live virus vaccine on cytomegalovirus diseases after renal transplant. Ann Int Med 114: 525-531
30. 30. Plotkin SA, Starr SE, Friedman HM, Gonezol E, Brayman K (1990) Vaccines for the prevention of human cytomegalovirus infection. Rev Infect Dis 12 [Suppl 7]: S827-S838
31. 31. Porath A, McNutt RA, Smiley LM, Weigle KA (1990) Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis 12: 31-40
32. 32. Rapp M, Messerle M, Lucin P, Koszinowski UH (1993) In vivo protection studies with mCMV glycoproteins gB and gH expressed by vaccinia virus. In: Michelson S, Plotkin SA (eds) Multidisciplinary approach to understanding cytomegalovirus disease. Elsevier, Amsterdam, pp 327-332
33. 33. Rapp M, Lucin P, Messerle M, Loh LC, Koszinowski UH (1994) Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus. J Gen Virol 75: 183-188
34. 34. Rasmussen LE, Nelson RM, Kelsall DC, Merigan TC (1984) Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus. Proc Natl Acad Sci USA 81: 876-880
35. 35. Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC (1991) Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis 164: 835-842
36. 36. Rixon FJ, McLauchlan J (1993) Herpes simplex virus vectors. In: Davison AJ, Elliott RM (eds) Molecular virology: a practical approach. Oxford University Press, New York, pp 285-307
37. 37. Schleiss MR (1994) Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene. Virology 202: 173-185
38. 38. Schleiss MR, Bourne N, Bernstein DI (1998) Recombinant expression of guinea pig cytomegalovirus (GPCMV) glycoprotein B: analysis of antibody responses following vaccination of guinea pigs for prevention of experimental congenital CMV infection. Pediatr Res 43: 252A
39. 39. Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67: 31-40
40. 40. Spaete RR, Perot K, Scott PI, Nelson JA, Stinski MF, Pachl C (1993) Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology 193: 853-861
41. 41. Spector DH, Klucher KM, Rabert DK, Wright DA (1990) Human cytomegalovirus early gene expression. Curr Top Microbiol Immunol 154: 21-45
42. 42. Urban M, Klein M, Britt WJ, Haßfurther E, Mach M (1996) Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response. J Gen Virol 77: 1 537-1 547
43. 43. Von Heijne G (1986) A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 14: 4 683-4 690
44. 44. Xu J, Dallas PB, Lyons PA, Shellam GR, Scalzo AA (1992) Identification of the glycoprotein H gene of murine cytomegalovirus. J Gen Virol 73: 1 849-1 854
45. 45. Xu J, Scalzo AA, Lyons PA, Farrell HE, Rawlinson WD, Shellam GR (1994) Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus. J Gen Virol 75: 3 235-3 240
46. 46. Yin C-Y, Gao M, Isom HC (1990) Guinea pig cytomegalovirus immediate-early transcription. J Virol 64: 1 537-1 548